TOGARAM1 and hepatocellular carcinoma: Among cancer studies, KIAA0423 rs1053667, a 3′ UTR polymorphism was found not associated with risk or OS in non‐Hodgkin's lymphoma or hepatocellular carcinoma and also not associated with prognosis in multiple myeloma patients undergoing autologous stem cell transplant 19, 42, 43, 44, 45.